Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

641
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
641
Benefits of Self-Esteem01:25

Benefits of Self-Esteem

192
Self-esteem—an individual's overall evaluation of their worth—plays a complex role in psychological functioning and well-being. It is often associated with many positive traits, such as confidence, optimism, and perseverance. Individuals with high self-esteem typically experience better sleep, manage peer pressure more effectively, and report greater life satisfaction. Conversely, low self-esteem has been consistently linked with increased risks of depression, anxiety, and poor...
192
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

719
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
719
Empirical Method to Interpret Standard Deviation01:09

Empirical Method to Interpret Standard Deviation

9.4K
The empirical rule, also known as the three-sigma rule, allows a statistician to interpret the standard deviation in a normally distributed dataset. The rule states that 68% of the data lies within one standard deviation from the mean, 95% lies within two standard deviations from the mean, and 99.7% lies within three standard deviations from the mean. Additionally, this rule is also called the 68-95-99.7 rule.
This rule is used widely in statistics to calculate the proportion of data values...
9.4K
Experimental Determination of Chemical Formula02:37

Experimental Determination of Chemical Formula

46.5K
The elemental makeup of a compound defines its chemical identity, and chemical formulas are the most concise way of representing this elemental makeup. When a compound’s formula is unknown, measuring the mass of its constituent elements is often the first step in determining the formula experimentally.
46.5K
Chemical Formulas02:52

Chemical Formulas

61.0K
A chemical formula presents information about the proportions of atoms constituting a particular chemical compound or molecule, mainly using symbols of elements and numbers. At times other symbols, such as dashes, parentheses, brackets, commas, plus, and minus signs, are also used. A chemical formula can be one of three types – molecular, empirical, and structural.
61.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measuring Atrioventricular Valve Regurgitation in Fontan Patients Using Cardiac MRI and the Association with Clinical Outcomes: A FORCE Study.

Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance·2026
Same author

Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUM.

BJPsych open·2026
Same author

Multicenter comparison of hybrid and Norwood procedures in patients with Fontan circulation.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Should lamotrigine be discontinued before TMS treatment: A report of three cases.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Same author

Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial.

BJPsych open·2026
Same author

Print, plan, perform: Evaluating the clinical impact of anatomical modelling in the surgical treatment of pediatric thoracic and abdominal tumours.

Journal of pediatric surgery·2026

Related Experiment Video

Updated: Jan 22, 2026

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.7K

Psychedelic microdosing benefits and challenges: an empirical codebook.

Thomas Anderson1, Rotem Petranker2, Adam Christopher3

  • 1Department of Psychology, University of Toronto, Mississauga, Canada. metathomas.anderson@mail.utoronto.ca.

Harm Reduction Journal
|July 11, 2019
PubMed
Summary
This summary is machine-generated.

Microdosing psychedelics, like LSD or psilocybin, shows benefits in mood and focus but also challenges like anxiety. This research categorizes these experiences to guide future scientific study.

Keywords:
AnxietyDepressionGrounded theoryLSDMicrodosingMoodOpen sciencePsilocybinPsychedelicSelf-efficacy

More Related Videos

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

7.2K
Author Spotlight: Deciphering the Cognitive and Neural Mechanisms of Gesture in Communication
07:18

Author Spotlight: Deciphering the Cognitive and Neural Mechanisms of Gesture in Communication

Published on: January 26, 2024

1.3K

Related Experiment Videos

Last Updated: Jan 22, 2026

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.7K
Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

7.2K
Author Spotlight: Deciphering the Cognitive and Neural Mechanisms of Gesture in Communication
07:18

Author Spotlight: Deciphering the Cognitive and Neural Mechanisms of Gesture in Communication

Published on: January 26, 2024

1.3K

Area of Science:

  • Psychopharmacology
  • Neuroscience
  • Mental Health Research

Background:

  • Microdosing psychedelics involves sub-hallucinogenic doses of substances like LSD or psilocybin.
  • Despite growing popularity, scientific research on microdosing remains limited, with few reports on adverse events.
  • Experiences of microdosers in community samples have not been systematically categorized.

Purpose of the Study:

  • To develop a comprehensive codebook of microdosing benefits and challenges (MDBC).
  • To categorize qualitative reports from a real-world sample of microdosers.
  • To identify high-potential intervention targets for future scientific research.

Main Methods:

  • Utilized qualitative reports from 278 individuals practicing microdosing.
  • Developed a codebook (MDBC) based on these self-reported experiences.
  • Analyzed findings for beneficial and challenging outcomes, including substance-dependent differences.

Main Results:

  • Identified key benefits: improved mood (26.6%) and focus (14.8%).
  • Identified key challenges: physiological discomfort (18.0%) and increased anxiety (6.7%).
  • Psilocybin-only users reported greater importance of benefits compared to other users.

Conclusions:

  • Mixed-methods results frame microdosing experiences for future research.
  • The MDBC taxonomy can inform efficient allocation of research funding.
  • This framework supports ongoing experimental microdosing research and clinical development.